Evidence map›Paper›PMID 40837788›Full record

ArticleWorld journal of psychiatry2025

Machine learning-based nomogram for predicting depressive symptoms in women: A cross-sectional study in Guangdong Province, China.

Jia-Min Chen, Mei Rao, Yu-Ting Wei, Qiong-Gui Zhou, Jun-Long Tao, Shi-Bin Wang, Bo Bi

Abstract read
In one paragraph

Article in World journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jia-Min ChenSchool of Public Health, Hainan Medical University, Hainan Academy of Medical Science, Haikou 571199, Hainan Province, China.
Mei RaoDepartment of Pharmacy, Longyan First Hospital Affiliated to Fujian Medical University, Longyan 364000, Fujian Province, China.
Yu-Ting WeiSchool of Public Health, Hainan Medical University, Hainan Academy of Medical Science, Haikou 571199, Hainan Province, China.
Qiong-Gui ZhouSchool of Public Health, Hainan Medical University, Hainan Academy of Medical Science, Haikou 571199, Hainan Province, China.
Jun-Long TaoSchool of Public Health, Hainan Medical University, Hainan Academy of Medical Science, Haikou 571199, Hainan Province, China.
Shi-Bin WangGuangdong Mental Health Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510000, Guangdong Province, China.
Bo BiSchool of Public Health, Hainan Medical University, Hainan Academy of Medical Science, Haikou 571199, Hainan Province, China. bibo@hainmc.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFemale depression is a prevalent and increasingly recognized mental health issue. Due to cultural and social factors, many female patients still face challenges in diagnosis and treatment, and traditional assessment methods often fail to identify high-risk individuals accurately. This highlights the necessity of developing more precise predictive tools. Utilizing machine learning (ML) algorithms to construct predictive models may overcome the limitations of traditional methods, providing more comprehensive support for women's mental health.

aimTo construct an ML-nomogram hybrid model that translates multivariate risk predictors of female depressive symptoms into actionable clinical scoring thresholds, optimizing predictive accuracy and interpretability for healthcare applications.

methodsWe analyzed data from 7609 female participants aged 18 to 85 years from the Guangdong Provincial Sleep and Psychosomatic Health Survey. Sixteen variables, including anxiety symptoms, insomnia, chronic diseases, exercise habits, and age, were selected based on prior literature and comprehensively incorporated into ML models to maximize predictive information utilization. Three ML algorithms, extreme gradient boosting, support vector machine, and light gradient boosting machine, were employed to construct predictive models. Model performance was evaluated using accuracy, precision, recall, F1 score, and area under the curve (AUC). Feature importance was interpreted using SHapley Additive exPlanations (SHAP), with ablation studies validating the impact of the top five SHAP-derived features on predictive performance, and a nomogram was constructed based on these prioritized predictors. Clinical utility was assessed through decision curve analysis.

resultsThe prevalence of depressive symptoms was 6.8% among the sample. The evaluation of predictive models revealed that light gradient boosting machine achieved a top-performing AUC of 0.867, placing it ahead of extreme gradient boosting (AUC = 0.862) and support vector machine (AUC = 0.849). SHAP analysis identified insomnia, anxiety symptoms, age, chronic disease, and exercise as the top five predictors. The nomogram based on these features demonstrated excellent discrimination (AUC = 0.910) and calibration, with significant net benefits in decision curve analysis compared to baseline strategies. The model effectively stratifies depressive symptoms risk, facilitating personalized and quantitative assessments in clinical settings. We also developed an interactive digital version of the nomogram to facilitate its application in clinical practice.

conclusionThe ML-based model effectively predicts depressive symptoms in women, identifying insomnia, anxiety symptoms, age, chronic diseases, and exercise as key predictors, offering a practical tool for early detection and intervention.

Indexed as

Depressive symptomsGuangdong ProvinceMachine learningNomogramPredictive modelingSHapley Additive exPlanationsWomen’s mental health

Identifiers

PMID40837788
PMCPMC12362627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.